Neuphoria Therapeutics Inc.

NEUP

—

Advanced chart & tools →

Neuphoria Therapeutics Inc.NEUP

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.23

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$15.65M

Net income

$-369,632

Net margin

-2.4%

Gross margin

—

Dividends & financials

Neuphoria Therapeutics Inc. (NEUP) reported revenue of $15.65M and net income of $-369,632, or $-0.23 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.